-
Document de presse | 2005.01.10
SouthEast Asia: Institut Pasteur Mobilizes
In response to the risk of epidemics in the regions affected by the disaster, the Institut Pasteur, which is engaged in the battle against infectious diseases on a daily basis, has mobilized. The expert in charge of the Institut Pasteur Emergency Cell for Biological intervention (CIBU) is currently on a mission in Sri Lanka to participate in evaluating the risk of epidemics in this region. At the...
-
Article | 2017.02.27
TT-RIIP International Course
TRANSGENIC TECHNOLOGIES in MODELING HUMAN DISEASES: Principles, Associated Technologies, Animal Management and Ethics
-
Document de presse | 2017.02.27
Infravec2 project launch: A European Commission 10M€ effort to fight mosquito-transmitted diseases
On February 14, the European Commission officially approved the Infravec2 project . This project will improve the European large-scale facilities (infrastructures) for research on mosquitoes and other insects (vectors) that carry human and animal diseases, and will promote sharing of the facilities by European researchers. The Infravec2 project is funded by the Commission’s Horizon 2020...
-
News | 2018.04.16
Halima Maïnassara: from field investigator to director of CERMES in Niger
In February 2017, Dr Halima Maïnassara is the first woman from Niger to be appointed Director General of the Center for Medical and Health Research (CERMES) in Niamey. Physician, epidemiologist expert in meningitis, she started to work for this public institution, member of the Institut Pasteur International Network, in February 2005 as a field investigator.Since primary school, Halima Boubacar...
-
Portrait | 2018.10.04
Anna-Bella Failloux, an all-terrain entomologist!
Close to 70 different nationalities work alongside each other on the Institut Pasteur's Paris campus, and Anna-Bella has come all the way from Tahiti. She was born in Papeete, French Polynesia and lived there until the age of 18. This small paradise conjures up idyllic images but it is blighted by mosquitoes. Maybe that is why Anna-Bella became a medical entomologist specializing in mosquito...
-
Fiche maladie | 2019.10.02
Influenza
Influenza is a contagious respiratory infection caused by influenza viruses, which are unique due to their vast genetic variability. It is a public health issue because of the seasonal outbreaks that affect 2 to 6 million people in France every winter, with influenza-associated excess mortality estimated at approximately 10,000 deaths, mainly in vulnerable individuals. The pandemic risk...
-
Fiche maladie | 2020.01.21
COVID-19 (SARS-CoV-2 virus)
The SARS-CoV-2 coronavirus, discovered in December 2019 in the province of Wuhan in China, is responsible for COVID-19. This highly contagious emerging infectious disease spreads by airborne transmission and surface contamination. Although COVID-19 can be asymptomatic, it can also cause a variety of symptoms, including severe respiratory distress that may prove fatal. Vaccination and basic health...
-
News | 2020.02.27
Foreign travel – a tonic for the health?
All travelers can come into contact with health risks that are completely different from those they generally encounter on a daily basis. So it is vital to prepare thoroughly for any trip – and that involves consulting a specialist travel clinic such as the Institut Pasteur Medical Center (CMIP).Travel is a formative experience for young people – and young people often take a casual attitude to...
-
Document de presse | 2022.05.18
Phage Therapy: A Model to Predict Its Efficacy against Pathogenic Bacteria
Antibiotic resistance represents a major public health challenge, associated with a high mortality rate. While bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers from Inserm, Université Sorbonne Paris Nord and Université Paris-Cité at the IAME...
-
Document de presse | 2023.06.02
Immunotherapy for blood cancer: remote destruction of tumor cells demonstrated
The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. Around 35,000 people are affected by blood cancer each year in France, with 1.24 million cases worldwide. By closely investigating some of the immune cells generated during this therapy, known as CD4 T...